Conventional Therapies Less Efficient in Cancer Patients with 'BRCA' Mutations

Share this content:
Conventional therapies are less efficient in cancer patients carrying 'BRCA' mutations
Conventional therapies are less efficient in cancer patients carrying 'BRCA' mutations
Prostate cancer patients carrying inherited mutations in the BRCA genes respond less well to conventional treatment, including surgery and/or radiotherapy - and they also have a lower survival rate than those who are non-carriers of these genetic mutations. Data from the study, which has been ...
READ FULL ARTICLE From Medical Express
Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


is free, fast, and customized just for you!

Already a member?

Sign In Now »